Avid Bioservices, Inc. (CDMO) Income statement

Market cap

$798.9M

P/E ratio

	2012/04	2013/04	2014/04	2015/04	2016/04	2017/04	2018/04	2019/04	2020/04	2021/04	2022/04	2023/04	2024/04
Revenue	15	22	22	27	45	58	54	54	60	96	120	149	140
Revenue growth (%)	-
Cost of revenue	-	-	-	-	-	-	57	46	56	67	83	118	133
Gross profit	-	-	-	-	-	-	-2,924,000	7	4	29	37	31	7
Gross margin (%)	-	-	-	-	-	-
Research & development	36	24	28	43	60	28	-	-	-	-	-	-	-
Selling, general & administrative	11	13	17	19	19	19	16	13	15	17	21	28	26
Operating margin (%)
Operating expenses	57	50	58	77	101	86	18	13	15	17	21	28	26
Operating income	-42,070,000	-28,352,000	-35,706,000	-50,499,000	-56,360,000	-28,260,000	-20,638,000	-6	-11	12	15	4	-19
Income before tax	-	-	-	-	-	-	-20,563,000	-5	-10	11	13	2	-27
Pretax margin (%)	-	-	-	-	-	-	-38.3	-10	-17.5	11.7	10.6	1.3	-19.2
Provision for income taxes	-	-	-	-	-	-	-	-0	-	-	-115	1	114
Effective tax rate (%)	-	-	-	-	-	-	-		-	-
Net income	-42,119,000	-29,780,000	-35,362,000	-50,358,000	-55,652,000	-28,159,000	-21,813,000	-4	-10	11	128	1	-141
Net income margin (%)
Earnings per share	-	-	-	-	-	-	-	-	-	-	2.08	0.01	-2.23
Diluted EPS	-	-	-	-	-	-	-	-	-	-	1.84	0.01	-2.23
EBITDA
EBITDA margin (%)